In tumor M-MDSCs with high glycolytic rates, several signaling pathways were downregulated, but the upregulation of phosphor-mTOR has been depicted as the main difference between tumor M-MDSCs and splenic M-MDSC. This evidence concerns the gene MTOR and neoplasm.